Alfred Baring Garrod (1819-1907).
Alfred Baring Garrod (1819-1907).
复制标题
阿尔弗雷德·巴林·加罗德 (1819-1907)。
DOI:
10.1093/rheumatology/40.10.1189
复制
发表时间:
2001
期刊:
影响因子:
5.5
通讯作者:
G. Storey
中科院分区:
文献类型:
--
作者:
G. Storey
Garrod was born in Ipswich. He was the son of Robert Garrod, himself the son of a tenant farmer who had founded a successful firm of auctioneers and estate agents. Alfred decided to follow a medical career. He was initially apprenticed to Charles Chambers Hammond at Ipswich Hospital but moved to University College Hospital, where he qualified MB in 1842 and MD in 1843. He was then appointed clinical assistant to the chemical department, where he ‘shall be occupied chiefly in the analysis of morbid fluids and other substances occurring in cases in the hospital and sent to him by the medical officer’. He was then assistant physician to the West London Hospital and also physician at the Aldersgate Dispensary and lecturer at the Aldersgate School 1846–7. In 1848 he made his major contribution to our knowledge of the causation of gout. At a public lecture on 8 February 1848, reported in the Medical Chirurgical Transactions, he demonstrated the increase in uric acid in the blood of patients with gout, whereas there was no such increase in acute rheumatism or Bright’s disease. At this time he was assistant physician to University College Hospital. Later, in 1854, he developed the ‘thread test’and, in 1859, demonstrated smaller quantities of uric acid in the normal serum. He also demonstrated deposits of urate in the articular cartilage of gout.The importance of his results did not at first receive universal acceptance and it was not until 1960 that Hollander identified uric acid crystals in the synovial fluid in gout. Garrod was appointed full physician to University College Hospital in 1849 and continued lecturing at the hospital, sometimes starting at 8 am in the summer. He played a full part in hospital affairs and organized the establishment of a museum of materia medica. In 1859 he made his other major contribution to rheumatology. It is likely that rheumatoid arthritis had been present as a disease for a long time, certainly since the time of Sydenham, but the nomenclature had been confused with terms like rheumatic gout, chronic rheumatism, rheumalgia, scorbutic rheumatism, etc. And it was not until 1800, when Londré Beauvais described typical cases with pathology, that it became clear that the disease was a separate entity. Garrod, in his treatise of 1859, discussed the differential diagnosis of these various conditions. He rejected the chronic rheumatism of Heberden and the rheumatic gout of Fuller and chose the name ‘rheumatoid arthritis’ for the disease, and provided illustrations. He divided it into acute, chronic and irregular forms of generalized and localized type. The name has remained ever since.